ELCC 2018: Industry Participation

The European Lung Cancer Congress 2018 (ELCC 2018), is the most important congress in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.

It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.

Fast facts: ELCC 2018

  • Expecting over 2000 international participants
  • Specialists and Key Opinion Leaders (KOLs) from all over the world in one place and as one community
  • 16 educational, 4 key note, 4 speciality, 4 MIS (Multidisciplinary Interactive Sessions) sessions as well as a variety of different key lectures running over the four days
  • An internationally renowned faculty
  • 9 Industry Satellite Symposia
  • Vibrant commercial exhibition
  • Excellent networking opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution of the following organisations in the ELCC Congresses over the years.

Past attendees
Abbott Laboratories Cis Bio International Novartis
AbbVie Clovis Oncology Olympus Medical Systems Europe
Agennix Daiichi Sankyo Europe Otsuka Pharmaceuticals
Amgen Elsevier Pfizer Oncology
Amoy Diagnostics Co. Ltd Eli Lilly Pfizer Merck Alliance
Ariad Pharmaceuticals GE Healthcare PharmaMar, S.A.
AstraZeneca GSK Qiagen
Bayer Schering Pharma Helsinn Healthcare Roche
Beacon Oncology Ltd Karl Storz Rosetta Genomics
Biocartis Merck Serono Sanofi
Boehringer Ingelheim Microsulis Medical Ltd. Varian Medical Systems
Bristol-Myers Squibb MSD Wisepress Ltd

How can I participate in ELCC 2018?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congresses.

Contact the ESMO Events Sponsorship Team for more details. We look forward to hearing from you!